Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute
Takeda
HistoSonics, Inc.
Medtronic - MITG
SWOG Cancer Research Network
Pfizer
Stanford University
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Elevation Oncology
Indiana University
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Ceevra, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sumitomo Pharma America, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Nebraska
University of Missouri-Columbia
Ludwig Institute for Cancer Research
Novartis
City of Hope Medical Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Washington University School of Medicine
Nektar Therapeutics
National Institutes of Health Clinical Center (CC)
Calithera Biosciences, Inc
University of Wisconsin, Madison
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Hoosier Cancer Research Network
SCRI Development Innovations, LLC
Pfizer
Pfizer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
Brown University